As of September 14, 2023, the FDA approval and CDC recommendations apply to the mRNA vaccines from Pfizer-BioNTech and Moderna. Another vaccine from Novavax is currently under FDA review. [This article will be updated when more information is available about the Novavax COVID vaccine.]